Event: ASCO GI 2022

0:29:15

ICAHO20 - ASCO Direct™ Highlights - Dr. Axel Grothey - Colorectal Cancer

0:13:13

ASCO Annual Meeting 2022 - Press Conference - Monday, June 6

0:12:24

GU ASCO Symposium 2022 Summary

0:01:10

Highlights in bladder cancer from ASCO 2022

0:01:28

Highlights in gastric and colorectal cancer at ASCO GI 2023

0:00:55

Managing adverse events associated with TKIs in CML

0:01:02

Key takeaways from ASCO 2022

0:06:11

ASCO 2022 poster presentation commented by Dr. Frank A. Giordano

0:02:09

The emerging role of ctDNA in the early diagnosis of GI cancers

0:00:49

GU cancer highlights at ASCO 2022

0:26:17

2022 GU ASCO Bladder Cancer Highlights

0:01:32

ASCO GI 2021: highlighting progress in rare cancers

1:54:16

SWOG Spring 2022 Hybrid Group Meeting: GI Committee

0:02:44

Association of pre-existing autoimmune disease & irAEs secondary to ICI therapy

0:02:58

Upcoming updates at ASCO GI 2021: POLO, ClarIDHy & COVID-19

0:00:46

UC highlights at ASCO 2022

0:02:46

Exploring real-world biomarker testing for patients with advanced esophageal cancers

0:01:16

Colorectal cancer updates at ASCO 2022

0:01:27

Takeaways in hepatocellular carcinoma at ASCO GI 2023

0:35:42

Immunotherapy in CRC | 2023 Best of GI Cancer Conference

0:12:53

HCC: Management of Adverse Events with New Therapeutic Approaches

0:11:36

Emerging data with immunotherapy in esophageal squamous cell carcinoma

0:02:53

RENOBATE: investigating regorafenib plus nivolumab as 1st-line therapy for unresectable HCC

0:02:32

Bosutinib in newly diagnosed CML: GI, liver, effusion, and renal safety characterization